Two-component injectables promise more stable, effective treatments but create new hurdles in reconstitution and delivery. From lyophilised powders to dual-chamber systems, this article explores how device innovation is making complex therapies simpler, safer, and more accessible beyond the clinic.
This article explores why heated tobacco remains niche despite major investment, showing how products prioritise compliance over experience and miss the simplicity and ritual smokers want. True progress will require rethinking design, physics, and industry-wide collaboration.
This article explores why most smokers haven’t embraced reduced-risk products, revealing how current vape and heated tobacco tech fails to deliver the ritual, satisfaction, and simplicity smokers still seek.
Our work with Credence MedSystems won a 2025 Red Dot Design Concept Award – but more importantly, it could change the lives of countless people who need to self-administer two drugs in one injection at home. Read more on the three insightsbehind project success.
This article explores why most smokers haven’t embraced reduced-risk products, revealing how current vape and heated tobacco tech fails to deliver the ritual, satisfaction, and simplicity smokers still seek.
This article, featuring insights from James Blakemore and Leigh Shelford, explores how ESCMID 2025 marked a shift from technology-led innovation to outcome-led diagnostics. Covering key themes including AMR, syndromic testing, sequencing, and AI, it highlights why usability, integration, and real-world impact are now critical to platform success.
This article, featuring insights from Tom Brittain, James Boonzaier and Jack Hornsby – the RAS leadership team at Cambridge Design Partnership – explores how a skunkworks approach, underpinned by capability, capacity and culture, enables surgical robotics companies to accelerate development, reduce risk, and bring new RAS technologies to market with speed and confidence.
This article, authored by Steve Augustyn, featuring insights from Krai Chatamra, VP of Clinical Development at Intrance Medical Systems, explores the necessity of advanced therapies that provide consistent symptom control to improve patient outcomes and enable a more independent lifestyle.
Fran Pencliffe of Cambridge Design Partnership explores the benefits of platform devices for parenteral delivery and outlines the challenges, risks and best practices when bringing a combination product to market in this way.
The pharma industry’s move towards larger volumes of subcutaneous (SC) therapeutics and home-based care is increasing the demand for self-administration devices. We recently partnered with KORU to explore innovations in infusion pump technology aimed at enhancing patient comfort and convenience
We recently partnered with Re-Vana Therapeutics, pioneers in sustained-release technologies for a range of eye diseases. In this article, Re-Vana's Patrick H. O'Ruane, along with Cambridge Design Partnership's Dariusz Zak and Fran Pencliffe, discuss how advancing sustained-release therapies can help ease the burden of acute treatments.
We recently collaborated with Lent Innovations to explore critical issues in pediatric epinephrine injectors. Our latest article features insights from Dr. Annie Lent and our Deputy Head of Drug Delivery, Steve Augustyn.